Roche Holding AG (OTCMKTS:RHHBY - Get Free Report)'s stock price passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $52.13 and traded as high as $57.57. Roche shares last traded at $57.26, with a volume of 1,356,317 shares.
Analyst Ratings Changes
Several analysts have recently issued reports on RHHBY shares. HSBC cut shares of Roche from a "buy" rating to a "hold" rating in a research report on Monday, July 6th. Zacks Research downgraded Roche from a "hold" rating to a "strong sell" rating in a research report on Tuesday, July 14th. Finally, Morgan Stanley raised Roche from an "equal weight" rating to an "overweight" rating and set a $63.00 price objective for the company in a research note on Friday. Five analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $60.00.
View Our Latest Stock Report on RHHBY
Roche Price Performance
The company's fifty day moving average price is $52.13 and its 200-day moving average price is $52.89. The company has a quick ratio of 1.12, a current ratio of 1.38 and a debt-to-equity ratio of 0.72.
Institutional Trading of Roche
Several institutional investors have recently added to or reduced their stakes in RHHBY. Confluence Investment Management LLC grew its stake in Roche by 1.2% in the second quarter. Confluence Investment Management LLC now owns 20,925 shares of the company's stock valued at $1,074,000 after purchasing an additional 258 shares during the last quarter. Oakworth Capital Inc. boosted its holdings in Roche by 20.8% in the fourth quarter. Oakworth Capital Inc. now owns 1,658 shares of the company's stock worth $86,000 after acquiring an additional 285 shares in the last quarter. Enterprise Financial Services Corp grew its stake in shares of Roche by 6.6% during the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company's stock worth $277,000 after acquiring an additional 345 shares during the last quarter. Archer Investment Corp increased its holdings in shares of Roche by 7.7% during the first quarter. Archer Investment Corp now owns 5,598 shares of the company's stock valued at $278,000 after acquiring an additional 398 shares in the last quarter. Finally, Diversified Trust Co raised its position in shares of Roche by 0.8% in the 1st quarter. Diversified Trust Co now owns 59,375 shares of the company's stock valued at $2,907,000 after purchasing an additional 448 shares during the last quarter.
About Roche
(
Get Free Report)
Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann‑La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY OTCMKTS: RHHBY.
In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Roche, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Roche wasn't on the list.
While Roche currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
